J&J exits the RSV vaccine development race with competitors Pfizer and GSK
March 30, 2023: On Wednesday, Johnson & Johnson said it’s ducking out of the RSV vaccine race, weeks following competitors Pfizer …
March 30, 2023: On Wednesday, Johnson & Johnson said it’s ducking out of the RSV vaccine race, weeks following competitors Pfizer …